Heart failure monitoring with a non-invasive lung fluid sensor
Part of Heart & circulation clinical trials.
This trial tests a new device that measures fluid in your lungs without needles or surgery. It may help your doctor manage heart failure better, especially if you've been in the hospital recently or have symptoms like shortness of breath.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with heart failure.
- Your heart failure symptoms limit your daily activities (NYHA class II, III, or IV), and if you are class II, you've been hospitalized for heart failure in the past year.
- You've had a specific blood test (NT-proBNP) showing elevated levels in the last 12 months.
- You can use the non-invasive sensor: your body mass index is between 22 and 39, and your height is between 155 cm and 195 cm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a wearable device that measures fluid in the lungs to help guide treatment for acute heart failure. It may help doctors better manage your condition and reduce symptoms like shortness of breath.
This study uses a noninvasive device (ReDS) to estimate fluid buildup in people hospitalized with acute heart failure. It may help doctors monitor fluid status and guide care more accurately during a hospital stay.
This study tests whether a small wireless sensor can safely measure and track pressure in the left upper heart chamber in people with advanced chronic heart failure. It may help the care team better understand pressure changes that are linked to fluid buildup and symptoms, alongside your usual heart medicines.
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.